Search Results for: Respiratory

2697 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
MTUS2 and NUBPL microtubule associated scaffold protein 2 nucleotide binding protein like
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
AGTPBP1 and CYCS ATP/GTP binding protein 1 cytochrome c, somatic
  • Carboxyterminal post-translational modifications of tubulin
  • Release of apoptotic factors from the mitochondria
  • Formation of apoptosome
  • Activation of caspases through apoptosome-mediated cleavage
  • SMAC (DIABLO) binds to IAPs
  • SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes
  • Transcriptional activation of mitochondrial biogenesis
  • Detoxification of Reactive Oxygen Species
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Regulation of the apoptosome activity
  • Regulation of the apoptosome activity
  • Minocycline
  • Protoporphyrin Ix Containing Co
  • Heme C
  • Imidazole
  • Protoporphyrin Ix Containing Zn
  • N-Trimethyllysine
  • Zinc Substituted Heme C
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
NDUFAF3 and KRTAP10-3 NADH:ubiquinone oxidoreductase complex assembly factor 3 keratin associated protein 10-3
  • Complex I biogenesis
  • Keratinization
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
NDUFAF3 and LSM1 NADH:ubiquinone oxidoreductase complex assembly factor 3 LSM1 homolog, mRNA degradation associated
  • Complex I biogenesis
  • mRNA decay by 5' to 3' exoribonuclease
  • mRNA decay by 5' to 3' exoribonuclease
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
NDUFAF2 and C5orf64 NADH:ubiquinone oxidoreductase complex assembly factor 2 chromosome 5 open reading frame 64
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
NDUFAF2 and ISCA1P1 NADH:ubiquinone oxidoreductase complex assembly factor 2 iron-sulfur cluster assembly 1 pseudogene 1
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
NOX1 and NOXO1 NADPH oxidase 1 NADPH oxidase organizer 1
  • RHO GTPases Activate NADPH Oxidases
  • WNT5:FZD7-mediated leishmania damping
  • RHO GTPases Activate NADPH Oxidases
  • WNT5:FZD7-mediated leishmania damping
  • Oxygen
  • Ecabet
NDOR1 and CYCS NADPH dependent diflavin oxidoreductase 1 cytochrome c, somatic
  • Cytosolic iron-sulfur cluster assembly
  • Release of apoptotic factors from the mitochondria
  • Formation of apoptosome
  • Activation of caspases through apoptosome-mediated cleavage
  • SMAC (DIABLO) binds to IAPs
  • SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes
  • Transcriptional activation of mitochondrial biogenesis
  • Detoxification of Reactive Oxygen Species
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Regulation of the apoptosome activity
  • Regulation of the apoptosome activity
  • Minocycline
  • Protoporphyrin Ix Containing Co
  • Heme C
  • Imidazole
  • Protoporphyrin Ix Containing Zn
  • N-Trimethyllysine
  • Zinc Substituted Heme C
  • Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
ACAD9 and SEC61A1 acyl-CoA dehydrogenase family member 9 SEC61 translocon subunit alpha 1
  • Complex I biogenesis
  • ER-Phagosome pathway
  • SRP-dependent cotranslational protein targeting to membrane
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
ACAD9 and HMCES acyl-CoA dehydrogenase family member 9 5-hydroxymethylcytosine binding, ES cell specific
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
ACAD9 and ISY1 acyl-CoA dehydrogenase family member 9 ISY1 splicing factor homolog
  • Complex I biogenesis
  • Formation of TC-NER Pre-Incision Complex
  • Transcription-Coupled Nucleotide Excision Repair (TC-NER)
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • mRNA Splicing - Major Pathway
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
CHMP4A and TTC19 charged multivesicular body protein 4A tetratricopeptide repeat domain 19
  • Budding and maturation of HIV virion
  • Macroautophagy
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • HCMV Late Events
  • Late endosomal microautophagy
  • Sealing of the nuclear envelope (NE) by ESCRT-III
SLC30A5 and NDUFAF2 solute carrier family 30 member 5 NADH:ubiquinone oxidoreductase complex assembly factor 2
  • Insulin processing
  • Zinc efflux and compartmentalization by the SLC30 family
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
A2M and ECSIT alpha-2-macroglobulin ECSIT signaling integrator
  • Platelet degranulation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Degradation of the extracellular matrix
  • Rho GTPase cycle
  • HDL assembly
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • Complex I biogenesis
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88 cascade initiated on plasma membrane
  • Becaplermin
  • Cisplatin
  • Bacitracin
  • Zinc
  • Ocriplasmin
A2M and RAB3A alpha-2-macroglobulin RAB3A, member RAS oncogene family
  • Platelet degranulation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Degradation of the extracellular matrix
  • Rho GTPase cycle
  • HDL assembly
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • GABA synthesis, release, reuptake and degradation
  • Becaplermin
  • Cisplatin
  • Bacitracin
  • Zinc
  • Ocriplasmin
A2M and PRDX2 alpha-2-macroglobulin peroxiredoxin 2
  • Platelet degranulation
  • Intrinsic Pathway of Fibrin Clot Formation
  • Degradation of the extracellular matrix
  • Rho GTPase cycle
  • HDL assembly
  • Detoxification of Reactive Oxygen Species
  • TP53 Regulates Metabolic Genes
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Becaplermin
  • Cisplatin
  • Bacitracin
  • Zinc
  • Ocriplasmin
  • 3-Sulfinoalanine
  • N-Carbamoyl-Alanine
  • Copper
AANAT and YWHAZ aralkylamine N-acetyltransferase tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
  • Serotonin and melatonin biosynthesis
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Deactivation of the beta-catenin transactivating complex
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • KSRP (KHSRP) binds and destabilizes mRNA
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Negative regulation of NOTCH4 signaling
  • Regulation of localization of FOXO transcription factors
  • Coa-S-Trimethylene-Acetyl-Tryptamine
  • Coa-S-Acetyl Tryptamine
  • Coa-S-Acetyl 5-Bromotryptamine
  • Phenethyl Isothiocyanate
  • Delayed sleep phase syndrome
ABAT and ALDH5A1 4-aminobutyrate aminotransferase aldehyde dehydrogenase 5 family member A1
  • Degradation of GABA
  • Degradation of GABA
  • Pyridoxal Phosphate
  • Pyruvic acid
  • Glutamic Acid
  • L-Alanine
  • Valproic Acid
  • Phenelzine
  • Vigabatrin
  • (4e)-4-Aminohex-4-Enoic Acid
  • 4-Amino Hexanoic Acid
  • Succinic acid
  • NADH
  • Valproic Acid
  • Chlormerodrin
  • Succinic semialdehyde dehydrogenase (SSADH) deficiency; 4-Hydroxybutyric aciduria (4-HBA)
ABL1 and BCR ABL proto-oncogene 1, non-receptor tyrosine kinase BCR activator of RhoGEF and GTPase
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • Myogenesis
  • Myogenesis
  • RHO GTPases Activate WASPs and WAVEs
  • HDR through Single Strand Annealing (SSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Cyclin D associated events in G1
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX2 regulates osteoblast differentiation
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Signaling by cytosolic FGFR1 fusion mutants
  • Rho GTPase cycle
  • Signaling by FGFR1 in disease
  • ATP
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • XL228
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • Myristic acid
  • 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
  • Brigatinib
  • Radotinib
  • Dasatinib
  • Bosutinib
  • Ponatinib
  • Chronic myeloid leukemia (CML)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
  • Chronic myeloid leukemia (CML)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
ABL1 and YWHAZ ABL proto-oncogene 1, non-receptor tyrosine kinase tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of ABL in ROBO-SLIT signaling
  • Role of ABL in ROBO-SLIT signaling
  • Myogenesis
  • Myogenesis
  • RHO GTPases Activate WASPs and WAVEs
  • HDR through Single Strand Annealing (SSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Cyclin D associated events in G1
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • RUNX2 regulates osteoblast differentiation
  • FCGR3A-mediated phagocytosis
  • Factors involved in megakaryocyte development and platelet production
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Deactivation of the beta-catenin transactivating complex
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • KSRP (KHSRP) binds and destabilizes mRNA
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • NOTCH4 Activation and Transmission of Signal to the Nucleus
  • Negative regulation of NOTCH4 signaling
  • Regulation of localization of FOXO transcription factors
  • ATP
  • Imatinib
  • Dasatinib
  • N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
  • Nilotinib
  • XL228
  • Bosutinib
  • 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
  • 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
  • Myristic acid
  • 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
  • 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
  • 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
  • Regorafenib
  • Ponatinib
  • Brigatinib
  • Radotinib
  • Phenethyl Isothiocyanate
  • Chronic myeloid leukemia (CML)
  • Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)

Page 19 out of 135 pages